Sign In
Buy ADC
$76.32
-0.590 (-0.767%)
At Close: Aug 04, 2026
Fire And Ice
09:00am, Sunday, 12'th Jan 2025
US equity markets tumbled this week while benchmark interest rates surged to the cusp of multi-decade highs after a critical slate of employment data showed surprisingly buoyant labor market trends. P
A Dozen Stocks I'm Buying As Rising Interest Rates Break The Market
08:05am, Saturday, 11'th Jan 2025
Interest rate peaks often cause short-term S&P 500 selloffs, especially for REITs. I retain hope that REITs may decouple from 10-year Treasury yields once rates stabilize. Baby Boomers' economic impac
Dividends On Repeat: 3 Monthly Payers You'll Love Forever
07:30am, Saturday, 11'th Jan 2025
Reliable monthly dividends are a game-changer for income investors, providing steady cash flow and financial peace of mind in any market. I share three top-notch monthly dividend payers that offer con
Agree Realty Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Information
04:05pm, Tuesday, 07'th Jan 2025
ROYAL OAK, Mich. , Jan. 7, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that it will release its fourth quarter and full year 2024 operating results after
Agree Realty Announces 2024 Investment Activity & 2025 Investment Outlook
04:05pm, Monday, 06'th Jan 2025
2025 Investment Guidance of $1.1 Billion to $1.3 Billion Balance Sheet Pre-Equitized with Liquidity of Over $2.0 Billion ROYAL OAK, Mich. , Jan. 6, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE:
Agree Realty: Still A Marginal Buy Case To Be Made Now
07:00am, Saturday, 04'th Jan 2025
A few months ago, Agree Realty upped its monthly dividend per share. The REIT delivered in the third quarter and looks positioned to keep generating solid AFFO per share growth. Agree Realty's credit
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:05pm, Thursday, 02'nd Jan 2025
LAUSANNE, Switzerland , Jan. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced tha
3 High-Yield Asset Classes For Dividend Investors In 2025
08:29pm, Wednesday, 01'st Jan 2025
Traditional dividend valuation methods may not apply to all asset classes. Business Development Companies like Blue Owl Capital offer high yields through diverse debt investments, benefiting from high
LAUSANNE, Switzerland , Dec. 30, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced th
What Are The Top REITs For 2025?
08:25am, Monday, 30'th Dec 2024
REITs are offering a once-in-a-decade opportunity. They are heavily discounted and some enjoy strong catalysts in 2025. This could lead to significant upside. Here are some of my top picks.
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug conjugate (ADC) DLL3 highly expressed in Small Cell Lung Cancer (SCLC) and Neuroen
2 REITs Investors Should Own In 2025
08:25am, Saturday, 28'th Dec 2024
The REIT market has something for everyone. There are income, growth, and deep value opportunities. But a few REITs have it all. We highlight 2 such REITs to own in 2025.
8 Stocks I'm Buying As I Hone My Buying Strategy For 2025
08:05am, Saturday, 28'th Dec 2024
I visualize my portfolio as a galley ship with rowers (steady compounders) and sails (high-yielding securities) for balanced growth and income. In 2025, my goal is to refocus on rowers to enhance divi
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.
04:05pm, Friday, 27'th Dec 2024
Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company's pipeline Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjuga
3 No-Brainer Dividend Stocks to Buy With $200 Right Now
09:15am, Thursday, 26'th Dec 2024
The S&P 500 dipped last week after the Federal Reserve said it's planning to slow the pace of its interest rate cuts in 2025. However, the index is still up 24% as we head toward the end of the year.
